Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, ...

Researchers at Tel Aviv University have developed a new platform using polymeric nanoparticles to deliver drug pairs to ...

Lifileucel is under clinical development by Iovance Biotherapeutics and currently in Phase I for Primary CNS Lymphoma.

INR:1965. blackjack 42 upgrades With the explosion of tyrosine kinase inhibitors and the proliferation of PD-1, where will the development of new drugs go?

Shares of Verastem Oncology (VSTM) are up over 40% at $5.17 in premarket trading Tuesday, following a regulatory update. The ...